Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_2
1
17%
Ph not_applicable
1
17%
Ph phase_1
2
33%
Ph phase_4
2
33%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_1

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

NCT01935869
completedphase_1

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

NCT02355639
completednot_applicable

Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization

NCT05353374
completedphase_2

Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.

NCT04951349
completedphase_4

Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment

NCT03799484
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01935869Phase 1

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

Completed
NCT02355639Phase 1

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

Completed
NCT05353374Not Applicable

Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization

Completed
NCT04951349Phase 2

Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.

Completed
NCT03799484Phase 4

Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment

Completed
NCT00179959Phase 4

The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6